FDBusiness.com

Lipogen expand facilities and build new phospholipids R&D center

 Breaking News
  • Diageo Launches New Super-premium Gin Diageo is introducing a new super-premium Italian gin, Villa Ascenti. The launch comes at a time when the super-premium and ultra-premium gin categories are the fastest growing segment within gin in Europe. Villa Ascenti will initially be available in 14 European countries. A new €420,000 (£360,000) distillery has been built on the site of the brand [...]...
  • European Commission Proposes to Increase Price Transparency in the Food Chain Having banned unfair trading practices and improved producer co-operation, the European Commission has presented the third element to improve fairness in the food supply chain by introducing greater transparency in the way prices are reported throughout the chain. The European Commission has tabled a proposal that will make available crucial information on how prices are determined [...]...
  • Irish Distillers Launches ‘A Story of Irish Whiskey’ Podcast Series Irish Distillers, Ireland’s leading supplier of spirits and wines and producer of some of the world’s most well-known and successful Irish whiskeys, has launched its first podcast, ‘A Story of Irish Whiskey’. Produced by Last Cast Media, the five-part series is a story of coming together, sharing, conquering markets and how three families, competitors for [...]...
  • C&C Group Increases Revenue by 187.3% to over €1.5 Billion C&C Group, the UK and Ireland drinks production and distribution business, increased net revenue by 187.3% to €1.575 billion in 12 months ended 28 February 2019, reflecting the acquisition of Matthew Clark and Bibendum from the administrators of Conviviality Group in April 2018. Excluding Matthew Clark and Bibendum, and on a constant currency basis, net [...]...
  • 2 Sisters Accelerates Business Transformation 2 Sisters Food Group has announced a series of actions as part of its accelerating transformational strategy to turnaround the business. The company is making further investments in its UK Poultry and Fox’s Biscuits businesses, and is proposing to reduce the number of its UK Poultry sites in order to produce shorter, more efficient supply [...]...

Lipogen expand facilities and build new phospholipids R&D center

November 16
09:27 2015

lipogenLipogen Ltd. is expanding its production facilities and building a new phospholipids research and development center.

The development is in response to a 50 percent jump in sales of brain and stress health solutions in Q1-Q3 2015.

Lipogen invested US$2.6 million in building two additional production lines for PhosphatidylSerine (PS) and Phosphatidic Acid (PA). The company also added 10,000 sq ft to its facilities to double production capabilities for PS and PA.

Upgrades include automated controlled processing to reduce production costs through improved production traceability, and implementing new safety methods, allowing Lipogen to produce its all-natural, non-GMO, solvent-free ingredients in accordance with the highest industry standards.

The PS market is forecast to grow significantly due to developments of new applications plus a growing demand in emerging markets, such as India and China.

Data from Nutrition Business Journal put the US cognitive health market at $1.2 billion by 2014 and estimates the market will hit almost $1.5 billion by 2020.

“Increasing demand for our brain health and stress management ingredients pushed us to establish a new growth strategy for our PS and PA product line,” says David Rutenberg, CEO of Lipogen. “The phospholipids market is expanding from traditional brain function support to new brain health concepts, including: stress management, cortisol control, ADHD mitigation, sports nutrition and more.”

Lipogen continues to research and develop new cognitive and stress management solutions based on proprietary technology and enzymatic process. The advanced, well-equipped phospholipids R&D center was designed to support product development and product research at Lipogen facilities. The company has appointed Abraham Rutenberg as VP and R&D manager. In addition, Lipogen expanded its headquarters, appointing Ariel Gordon as VP Business Development manager to develop new segments and markets for Lipogen’s leading brands.

“I’m excited to welcome Abraham Rutenberg and Ariel Gordon to our team,” said Mr Rutenberg. “They will lead Lipogen to the next level via high-impact growth—not only in the dietary supplements industry, but also in the food, beverage and pharmaceuticals industries. Lipogen is committed to producing pure, high-quality products with minimal damage to the environment. We’ve initiated a long-term sustainability strategy for our complete product line.”

With 25 years of specializing in natural phospholipid research, development and production, Lipogen guarantees its customers ingredient systems that are supported by the highest level of scientific data, technical quality and safety to meet the growing demand for natural cognitive health solutions.

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • June 18, 2019Multimodal 2019
  • June 25, 2019BevExpo 2019
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements